Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also strengthening its central nervous system portfolio through strategic in-licensing deals and acquisitions, particularly in ADHD and Parkinson's disease. The company is also focusing on innovation-led solutions to combat antimicrobial resistance and aims to be a global, patient-centric healthcare leader.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CnbNVQU
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Cipla eyes entry into India's weight management market amid rising demand and global competition
0 comments:
Post a Comment